4-fluoro-3-nitrobenzoic acid is a synthetic organic compound, often used as an intermediate in the synthesis of other chemicals, including pharmaceuticals. Its importance lies in its ability to act as a building block for various chemical reactions. Due to its chemical structure, it exhibits specific reactivity patterns and forms unique derivatives. Research on this compound often focuses on understanding its reactivity, its potential applications in organic synthesis, and its biological activity. The compound is studied in various fields such as pharmaceutical chemistry, materials science, and organic chemistry.'
```
| ID Source | ID |
|---|---|
| PubMed CID | 67987 |
| SCHEMBL ID | 24994 |
| MeSH ID | M0217493 |
| Synonym |
|---|
| AC-3149 |
| 4-fluoro-3-nitrobenzoic acid , |
| p-fluoro-3-nitrobenzoic acid |
| nsc-10311 |
| nsc10311 |
| 453-71-4 |
| inchi=1/c7h4fno4/c8-5-2-1-4(7(10)11)3-6(5)9(12)13/h1-3h,(h,10,11 |
| 4-fluoro-3-nitrobenzoic acid, ~99% |
| 4-fluoro-3-nitrobenzoic acid, 98% |
| STK498478 |
| AKOS000283434 |
| F0399 |
| A7154 |
| 3-nitro-4-fluorobenzoic acid |
| unii-4xu69fau2v |
| nsc 10311 |
| 4xu69fau2v , |
| einecs 207-221-3 |
| BBL010573 |
| FT-0618488 |
| AM20060114 |
| AB00828 |
| 3-nitro-4-fluoro-benzoic acid |
| 4-fluoro-3-nitro-benzoic acid |
| 3-nitro-4-flurobenzoic acid |
| 4-fluoro-5-nitrobenzoic acid |
| 4-fluoro-3-nitro benzoic acid |
| 3-nitro-4-fluoro benzoic acid |
| SCHEMBL24994 |
| SY004060 |
| mfcd00007058 |
| W-106140 |
| benzoic acid, 4-fluoro-3-nitro- |
| Z89284934 |
| CS-W008650 |
| DTXSID30196465 |
| AS-10821 |
| (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetic acid (levetiracetam acid) |
| EN300-18726 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.34) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||